Skip to content
Use caution Drug recall · FDA · Published October 20, 2025

Golden State Recalls Niacin 1000mg Due to Dissolution Failure

Golden State Medical Supply recalls 24,869 bottles of Niacin 1000mg tablets due to failed dissolution specifications. Check your lot numbers.

🇺🇸 FDA recall #D-0158-2026DrugGolden State Medical Supply ›
Take action

Contact the company

Recalling firmGolden State Medical Supply Inc.5187 Camino Ruiz · Camarillo, CA 93012-8601
✎ GovInfoNow plain-language explainer

What happened, in plain English

Golden State Medical Supply Inc. is recalling Niacin Extended-Release Tablets, USP, 1,000 mg because they have failed dissolution specifications. This means the medication may not release or absorb properly in the body. The recall affects 24,869 bottles distributed nationwide. Read more at govinfonow.com/recall/31686-golden-state-recalls-niacin-1000mg-due-to-dissolution-failure.

Source Summary by GovInfoNow · govinfonow.com/recall/31686-golden-state-recalls-niacin-1000mg-due-to-dissolution-failure · Updated October 9, 2026 · FDA enforcement record: FDA #D-0158-2026

Cite this page

“Golden State Recalls Niacin 1000mg Due to Dissolution Failure.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/31686-golden-state-recalls-niacin-1000mg-due-to-dissolution-failure. Based on FDA recall #D-0158-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0158-2026%22&limit=1).

Why it’s dangerous

The tablets failed dissolution specifications, which is a quality control issue where the drug does not break down as intended. This can result in the body not absorbing the correct amount of niacin, potentially leading to ineffective treatment for cholesterol or other conditions.

Who’s affected

Patients who have been prescribed Niacin Extended-Release Tablets by Golden State Medical Supply Inc. are affected. Individuals taking this specific medication may not receive the full therapeutic benefit due to the manufacturing defect.

How to tell if you have this one

Look for Niacin Extended-Release Tablets, USP, 1,000 mg in bottles containing 90 tablets. The product is Rx only and manufactured by Kremers Urban Pharmaceuticals, Inc. Check the bottle for NDC 51407-268-90 and one of the listed lot numbers (e.g., GS044385, GS044979) with expiration dates ranging from October 2025 to May 2026.

  • Brand
    Golden State Medical Supply
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches the recalled NDC and lot numbers listed in the record.

  2. Contact Your Pharmacist

    Speak with your healthcare provider or pharmacist to determine the next steps for your prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Oct 20, 202512. FDA classified it Class II: Nov 19, 202523. Published in FDA’s Enforcement Report: Nov 26, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are included in this recall?

Recalled lots include GS044385, GS044979, GS045797, GS046415, GS047197, GS047786, GS048477, GS049480, GS048873, GS049733, GS050224, GS050721, GS050722, GS051145, GS051726, GS052484, GS053612, GS054987, GS054409, GS055697, GS056192, GS056886, GS058077, and GS057330.

Similar recalls

Other Golden State Medical Supply recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0158-2026 (October 20, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0158-2026 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA